Article

Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration

Harvard Stem Cell Institute, Cambridge, MA 02138, USA.
Cell (Impact Factor: 32.24). 04/2009; 136(6):1136-47. DOI: 10.1016/j.cell.2009.01.015
Source: PubMed

ABSTRACT

Interactions between developmental signaling pathways govern the formation and function of stem cells. Prostaglandin (PG) E2 regulates vertebrate hematopoietic stem cells (HSC). Similarly, the Wnt signaling pathway controls HSC self-renewal and bone marrow repopulation. Here, we show that wnt reporter activity in zebrafish HSCs is responsive to PGE2 modulation, demonstrating a direct interaction in vivo. Inhibition of PGE2 synthesis blocked wnt-induced alterations in HSC formation. PGE2 modified the wnt signaling cascade at the level of beta-catenin degradation through cAMP/PKA-mediated stabilizing phosphorylation events. The PGE2/Wnt interaction regulated murine stem and progenitor populations in vitro in hematopoietic ES cell assays and in vivo following transplantation. The relationship between PGE2 and Wnt was also conserved during regeneration of other organ systems. Our work provides in vivo evidence that Wnt activation in stem cells requires PGE2, and suggests the PGE2/Wnt interaction is a master regulator of vertebrate regeneration and recovery.

Download full-text

Full-text

Available from: Gilbert Weidinger
    • "The anti-apoptotic action of PGE 2 is associated with PGE 2 -induced upregulation of anti-apoptotic proteins such as BCL-2 and activation of nuclear factor-κB (NF-κB) transcriptional activity in colorectal cancer (Sheng et al. 1998; Poligone & Baldwin 2001). PGE 2 inhibits apoptosis in mouse embryonic stem cells via an EP2–PI3K–Akt cascade and plays a key role in regulating the growth and development of both embryonic hematopoietic stem cells and adult stem cells in several different organisms (North et al. 2007; Goessling et al. 2009; Wang & Dubois 2010). Thus, cancer progression can be prevented by inhibiting inflammatory PGE 2 , or altering its regulation by the use of different potent phytochemicals. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The COX-2 metabolite prostaglandin E2 (PGE2) promotes inflammation and progression of several cancers, including colon cancer. Resveratrol (3,5,4′-trihydroxy-trans-stilbene) induces apoptosis in cell lines and inhibits the invasion and metastasis of human colon cancer. PGE2 inhibits resveratrol-induced cell death; however, the underlying mechanisms are poorly understood. Therefore, the present study investigates the protection and survival effect of PGE2 against resveratrol-induced apoptosis in a human colorectal carcinoma (HCT-15) cell line. HCT-15 cells were treated with resveratrol and/or PGE2, and apoptotic cell death was assessed based on flow cytometry and the generation of reactive oxygen species (ROS). Resveratrol reduced HCT-15 cell viability and induced cell death through the production of ROS and the activation of caspase-3. Resveratrol treatment degraded poly (ADP-ribose) polymerase (PARP) in response to caspase-3 cleavage. Resveratrol treatment also decreased the activation of Ras-Raf-Erk and nuclear factor-κB (NF-κB) pathways and downregulated COX-2 expression, but did not regulate the secretion of extracellular PGE2. However, PGE2 exposure reversed resveratrol-induced oxidative stress and apoptosis, possibly through activation of the Ras-Raf-Erk pathway. PGE2 also positively regulated NF-κB activation and markedly increased the nuclear appearance of p50 and p65 subunits. Thus, this study provides insight into the mechanisms of resveratrol-induced apoptosis. Our results suggest that the inhibition of PGE2 and PGE2-induced activation of Ras-Raf-Erk and NF-κB signaling pathways may provide an alternative therapeutic strategy for the treatment and prevention of colon cancer.
    No preview · Article · Nov 2015 · Animal cells and systems the official publication of the Zoological Society of Korea
  • Source
    • "Adapted from Solá et al. (2012). E 2 (PGE 2 ) production and release from apoptotic cells, which caused the activation of the Wnt/β-catenin pathway in neighboring nonapoptotic cells (Castellone et al., 2005; Zhao et al., 2006; Goessling et al., 2009) (Figure 2). It has been shown that this mechanism also plays a role in wound healing in mammalian cells by increasing the proliferation of keratinocyte progenitor cells by caspase-3 and -7 (Li et al., 2010). "

    Full-text · Article · Oct 2015
  • Source
    • "PGE 2 is important in various brain functions , including the masculinization of the brain and behavior (Amateau & McCarthy, 2004; Lenz et al., 2013), dendritic spine formation (Amateau & McCarthy, 2002), synaptic plasticity (Koch et al., 2010), calcium regulation in growth cones (Tamiji & Crawford 2010b), and the survival, proliferation, migration and differentiation of neural stem cells (Jiang et al., 2010). Moreover, it is capable of modifying the signaling of crucial developmental pathways , including the Wnt signaling pathway (Buchanan & DuBois, 2006; Evans, 2009; Goessling et al., 2009; Wong et al., 2014). It has previously been described that abnormal PGE 2 signaling [which can result from genetic defects or exposure to environmental factors, including deficient dietary supplementation, increased exposure to drugs (i.e. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of Autism Spectrum Disorders (ASDs) has been on the rise over recent years. The presence of diverse subsets of candidate genes in each individual with an ASD and the vast variability of phenotypical differences suggest that the interference of an exogenous environmental component may greatly contribute to the development of ASDs. The lipid mediator prostaglandin E2 (PGE2 ) is released from phospholipids of cell membranes and is important in brain development and function; PGE2 is involved in differentiation, synaptic plasticity, and calcium regulation. Our previous review already described extrinsic factors including deficient dietary supplementation and exposure to oxidative stress, infections, and inflammation that can disrupt signalling of the PGE2 pathway and contribute to ASDs. In this review, we describe the structure and establishment of two key protective barriers for the brain during early development: the blood brain barrier and the placental barrier. We then provide the first comprehensive summary of other environmental factors-such as exposure to chemicals in air pollution, pesticides, and consumer products-that can also disturb PGE2 signalling and increase the risk for developing ASDs. We also describe how these exogenous agents are capable of crossing the protective barriers of the brain during critical developmental periods when barrier components are still being formed. This review underlines the importance of avoiding or limiting exposure to these factors during vulnerable periods in development. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Full-text · Article · Jul 2015 · European Journal of Neuroscience
Show more